M.D. Sass Selected as PSN 'Top Guns Manager of the Decade'

NEW YORK, Feb. 23 /PRNewswire/ -- M.D. Sass, a leader in investment management for thirty-seven years, is pleased to announce that it has been selected as PSN Top Guns Manager of the Decade in the Large Cap Universe for the outperformance of its flagship Relative Value Equity strategy.

"At M.D. Sass, we believe the most attractive investment opportunities are often found outside the bounds of conventional wisdom," said Martin D. Sass, CEO of M.D. Sass. "Our Relative Value Equity strategy looks past popular market perceptions for attractive opportunities that others fail to discern. It has outperformed the market across multiple periods, so we are truly honored to be recognized in this way."

M.D. Sass was selected for its 10-year outperformance in the Relative Value Equity strategy as of Dec. 31, 2009. The selection universe consists of all domestic large cap equity managers (Value, Core, and Growth) benchmarked against the Russell 1000 Index. During the past 10 years this M.D. Sass equity strategy achieved a +7.6% gross (+6.6% net) annualized return compared with declines of -0.5 % annualized for the Russell 1000 Index and -0.95% annualized for the S&P 500 during the same period.

The M.D. Sass Relative Value Equity strategy seeks to outperform relevant equity market indices through forensic research and strong buy/sell disciplines. The firm's equity analysts search for high quality companies that they believe are misperceived or out of favor with strong long-term earnings growth prospects.

About M.D. SASS

M.D. Sass has been a leading name in investment management for thirty-seven years. Our clients include some of the world's largest corporations, financial institutions, state and local governments, endowment funds, foundations, Taft Hartley funds and high net worth individuals. Using a proven investment philosophy and rigorous research, we tailor a broad spectrum of investment strategies for clients across equities, fixed income and alternative investments. M.D. Sass's mission is to be the best investment management firm through superior risk-adjusted returns with the highest degree of client service and ethical standards.

Past performance is not indicative of future results.  M.D. Sass does not guarantee any minimum level of investment performance or the success of any investment strategy. M.D. Sass does not provide tax or legal advice, or determine an investor's investment objectives, risk tolerance, or suitability.  The gross and net returns for the Relative Value Equity strategy reflect composite returns and includes changes in securities prices and re-investment of capital gains and dividends, if any; the gross return is calculated gross of investment management and custodial fees and net of transaction costs, and the net return is calculated gross of custodian fees and net of management fees by using a tiered fee schedule for the periods starting with 1/1/2004 and returns prior to 1/1/2004 are calculated using a 1.00% fee based on a minimum $10 million investment.

The Russell 1000 Index measures the performance of the large-cap segment of the U.S. equity universe. It is a subset of the Russell 3000® Index and includes approximately 1,000 of the largest securities based on a combination of their market cap and current index membership. The Russell 1000 represents approximately 90% of the U.S. market. The S&P 500 Index is a capitalization weighted index that measures the performance of those companies that Standard and Poor's has selected for inclusion.  Both the Russell 1000 Index and the S&P 500 Index are unmanaged and may not be invested in directly.

SOURCE M.D. Sass

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED